Ceragon Q3 Revenue Up 11.7% to $95.5M; 2026 Revenue Outlook $365-375M
CRNT is trading near its 52-week low of $1.85 (14% above the low).
Summary
Ceragon reported Q3 2026 revenue of $95.5 million, up 11.7% year-over-year, with 36.0% gross margin and $14.1 million of operating cash flow, and guided full-year 2026 revenue to $365-375 million.
Key Events · Earnings and Guidance · CRNT
-
Q3 Revenue Grows 11.7% to $95.5M
Revenue rose to $95.5 million from $85.5 million in Q3 2025, with North America at 40% and India at 35% of the mix.
-
Margins Expand, Cash Flow Turns Strong
Gross margin reached 36.0%, up 430 basis points sequentially, and operations generated $14.1 million of cash in the quarter.
-
2026 Outlook Set at $365-375M Revenue
Management guided full-year 2026 revenue of $365-375 million, with non-GAAP gross margin of 33.5%-34.5% and non-GAAP operating margin of 5%-6% at the midpoint.
-
Profitability Still Thin on GAAP Basis
GAAP operating income was $4.5 million and GAAP net income $2.4 million, or $0.03 per diluted share; the nine-month net loss was $1.1 million.
Analysis · CRNT · Manufacturing
Revenue grew 11.7% year-over-year to $95.5 million, gross margin expanded to 36.0%, and the quarter generated $14.1 million of operating cash. Ceragon also reset its full-year 2026 outlook to $365-375 million of revenue with a 5%-6% non-GAAP operating margin, giving investors the first hard numbers on the second half after August's margin-guidance cut. Profitability remains thin — GAAP operating income was $4.5 million and nine-month net income is still a $1.1 million loss — so the margin trajectory and the India supply constraints flagged by the CEO are the swing factors for the rest of the year.
How filings like this one have moved
In the 30 days to Nov 5, 2026, 43.5% of the 1291 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.16%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CRNT was trading at $2.10 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $181.8M. The 52-week trading range was $1.85 to $3.29. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.